MedPath

Single dose study of new antimalarial drug to evaluate blood levels in healthy volunteers

Phase 1
Completed
Registration Number
CTRI/2012/07/002832
Lead Sponsor
CDRI Lucknow
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
16
Inclusion Criteria

Healthy adult males

Blood biochemistry and hematology - wnl

Stool and urine R/E - normal

Exclusion Criteria

Any medical or psychiatric illness

History of drug abuse

Refusal to give consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath